Vitura Health has nominated four new directors to join its board, with CDA Health co-founder Guy Headley among those stepping down.
Following a review of the skills, experience and expertise required to successfully deliver on the firm’s strategy reset, the board has nominated Shane Tanner, Rebecca Wilson, Gerard Fogarty AO and Daniel Birch to be appointed as new directors at its Annual General Meeting on November 27, subject to shareholder approval.
Vitura said Headley had expressed a desire to step down from the board while continuing to act for the company in an advisory capacity. Jenelle Frewen will also step down but remain as an advisor on government affairs. Marcia Walker has elected not to stand for re-election.
Vitura’s independent non-executive chairman Robert Iervasi, who is up for re-election at the AGM, said: “The board renewal completes our reset of Vitura. We started with strategy, supplemented this with an appropriate structure and we have now completed the picture with the right balance of board skills to take the business forward.
“I am pleased that we have retained the services of Guy Headley and Jenelle Frewen in an ongoing advisory capacity, and welcome a new pool of directors into the business. Our collective focus going forward will be on market execution and deliverables.”
“I would also like to thank Guy, Jenelle and Marcia for their dedication and contribution to Vitura as directors. All three individuals have demonstrated excellent qualities and commitment in supporting the governance and stewardship of Vitura.”
Headley added: “Following more than eight busy years… the time has come for me to pass on the baton to others. The recent appointment of our new CEO and the refreshed management team has given me the confidence that the company is in great hands.
“I will continue to provide my full support… as I remain a significant shareholder and advisor and look forward to the exciting implementation of the company’s strategy over the coming years.”
Elizabeth Jansen, a trustee of major Vitura shareholder the Stanford Investment Trust, welcomed the move.
“We are comforted that all the 2023 board members have decided to exit to enable the
company to grow and flourish into the future,” she said in a statement following the announcement.
“We welcome Rob Iervasi as new chairman… to reset the board and company.”
